CALC - CIK 0001534133
The table below shows CalciMedica, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $15.23M | $14.48M | $15.86M | $8.35M | $18.90M | $20.96M |
| SG&A | $7.89M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $9.73M |
| $22.22M |
| $5.84M |
| $17.04M |
| $8.87M |
| Operating income | -$23.12M | -$24.20M | -$38.08M | -$14.19M | -$35.95M | -$29.83M |
| Income tax | $0.00 | $0.00 | $1.00K | $1.00K | - | - |
| Net income | -$29.56M | -$13.70M | -$34.36M | -$7.82M | -$35.82M | -$27.53M |
| EPS (diluted) | -$1.97 | -$1.22 | -$7.66 | -$111.16 | -$1.69 | - |